Allergan Recalls McGhan BioDIMENSIONAL Silicone-Filled Breast Implants
Allergan PLC is recalling McGhan BioDIMENSIONAL silicone-filled breast implants due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) associated with textured implants.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class I, which the rubric mandates a minimum score of 4 (Severe). Additionally, the hazard involves a known cancer (BIA-ALCL) associated with the device.
Plain-English summary
Allergan PLC is recalling McGhan BioDIMENSIONAL silicone-filled breast implants, style 153, used for breast augmentation and reconstruction. The recall covers 4,026,287 breast implants and tissue expanders combined.
The action was initiated following notification by the U.S. Food and Drug Administration (FDA) regarding updated global safety information. This information indicates a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
The affected products were distributed worldwide and nationwide in the United States, including all 50 states, the US Virgin Islands, and Puerto Rico. International distribution included Bermuda, Canada, Chile, Japan, Korea, Thailand, Taiwan, and Vietnam. All lots are affected.
The recalled product
- Product
- McGhan BioDIMENSIONAL silicone-Filled Breast Implants, style 153 Product Usage: Breast augmentation and Breast reconstruction
- Manufacturer
- Allergan PLC
- Category
- Medical Device — Breast Implants
- Affected units
- 4,026,287
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- ALL LOTS
Distribution
Part of a larger recall action
This product is one of 15 recalled by Allergan PLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 15 products in this recall →Related recalls
Same manufacturer · Allergan PLC
See all →- ModerateAllergan Recalls Refresh Contacts Comfort Drops Due to Missing Instructions
FDA (Devices) · 2021-02-10
- ModerateAllergan Recalls Refresh Relieva Preservative-Free Eye Drops for Missing Labeling
FDA (Drugs) · 2021-01-27
- LowAllergan Recalls Skin Medica Acne System Kits for Subpotency
FDA (Drugs) · 2020-08-05
- ModerateAllergan Recalls Subpotent Skin Medica Acne Treatment Lotion
FDA (Drugs) · 2020-08-05
- LowAllergan Recalls Breast Implant Sizers Due to Unreadable Barcodes
FDA (Devices) · 2019-12-25
Same hazard · cancer
See all →- SevereAllergan Recalls Textured Breast Implants Due to Lymphoma Risk
FDA (Devices) · 2019-09-18
- CriticalAllergan Recalls Textured Breast Implants Due to Lymphoma Risk
FDA (Devices) · 2019-09-18
- SevereAllergan Recalls Natrelle Tissue Expanders Due to Lymphoma Risk
FDA (Devices) · 2019-09-18